South India’s Pharma Growth Story: Chennai, Kerala & Telangana in Focus
South India's Pharma Growth Story: Chennai, Kerala & Telangana in Focus South India has firmly established itself as the...
From NSAID combinations to joint-support formulations, every batch is manufactured under WHO-GMP conditions and tested before release.
Manufactured across four core categories within the segment.
South India's Pharma Growth Story: Chennai, Kerala & Telangana in Focus South India has firmly established itself as the...
Biosimilars in India: Where the Opportunity Is Heading Through 2030 India’s pharmaceutical industry is entering an important growth phase,...
How US Tariffs on Pharma Imports Could Reshape Indian Manufacturing Demand The global pharmaceutical industry is closely connected through...
India’s $32 Billion Pharma Export Target: What’s Driving the Growth India’s pharmaceutical industry is entering a new phase of...
Our dedicated customer support team just a message or call away